Finance

Lists
Why is 290650 down 4.71%?
Dive Deeper
290650:KOSDAQ
L&C Bio Co Ltd
₩66,800.00
-4.71%
(-3,300.00) 1D
Oct 19, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 290650...
Open
₩69,400
High
₩69,900
Low
₩61,500
Mkt. cap
2.05T
Avg. vol.
310.46K
Volume
574.42K
Dividend
0.07%
Quarterly dividend
₩12
Ex-dividend date
Sep 3, 2026
52-wk high
₩120,881
52-wk low
₩40,761
EPS
-₩6,030
Shares outstanding
26.97M
No. of employees
183
Open
₩69,400
High
₩69,900
Low
₩61,500
Mkt. cap
2.05T
Avg. vol.
310.46K
Volume
574.42K
Dividend
0.07%
Quarterly dividend
₩12
Ex-dividend date
Sep 3, 2026
52-wk high
₩120,881
52-wk low
₩40,761
EPS
-₩6,030
Shares outstanding
26.97M
No. of employees
183
News stories
From web sources and news partners
About L&C Bio Co Ltd
CEOLee Hwan-chul
Employees183
Founded2011
Headquarters-
SectorBiotechnology
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
22.56B
24.67B
30.29B
38.79B
Cost of goods sold
9.38B
11.58B
11.94B
15.17B
Cost of revenue
9.38B
11.58B
11.94B
15.17B
Research and development expenses
880.96M
1.05B
1.25B
1.78B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.36B
8.91B
10.14B
11.96B
Operating expense
10.28B
12.13B
12.35B
15.04B
Total operating expenses
19.66B
23.71B
24.30B
30.21B
Operating income
2.90B
954.55M
6.00B
8.58B
Other non operating income
-54.17B
-16.26B
2.81M
-12.46B
EBT including unusual items
-51.33B
-94.05B
3.01B
-7.12B
EBT excluding unusual items
-51.27B
-19.64B
5.27B
-4.49B
Income tax expense
7.33M
-21.53B
286.59M
21.01B
Effective tax rate
-0.01%
22.89%
9.51%
-295.22%
Other operating expenses
-
-
-
-
Net income
-51.46B
-72.56B
2.60B
-28.00B
Net profit margin
-228.14%
-294.12%
8.59%
-72.19%
Earnings per share
-
-
-
-1.06K
Interest and investment income
-
1.64B
344.76M
479.98M
Interest expense
-
-5.87B
-1.69B
-1.08B
Net interest expenses
-
-4.22B
-1.34B
-601.91M
Depreciation and amortization charges
885.12M
922.46M
787.97M
926.98M
EBITDA
4.98B
3.18B
8.09B
11.17B
Gain or loss from assets sale
576.38M
-528.80M
-18.11M
7.17M
AI content may include mistakes. Learn more
Google apps